Table 4.

Reactive arthritis (ReA) and musculoskeletal and mucocutaneous symptom comparisons among patients with clinical salmonellosis in relation to antibiotic treatment during the infection period. Relative risk (RR) and 95% confidence interval.

SymptomsAntibiotics, n = 56 (%)No Antibiotics, n = 92 (%)Crude RR (95% CI)Adjusted RR* (95% CI)
Reactive arthritis5 (9)10 (11)0.85 (0.30–2.36)0.43 (0.19–1.08)
Peripheral arthritis symptoms25 (45)56 (61)0.75 (0.53–1.04)0.65 (0.46–0.92)
Axial arthritis symptoms24 (43)43 (47)0.93 (0.64–1.35)0.84 (0.56–1.24)
Peripheral or axial arthritis symptoms30 (54)64 (70)0.78 (0.59–1.03)0.73 (0.55–0.98)
Joint symptoms33 (59)64 (70)0.86 (0.67–1.11)0.83 (0.64–1.08)
Mucous symptoms27 (48)41 (45)1.10 (0.77–1.57)0.94 (0.64–1.39)
Mucocutaneous symptoms30 (54)50 (54)1.00 (0.74–1.36)0.87 (0.63–1.21)
Any symptom43 (77)75 (82)0.95 (0.81–1.14)0.93 (0.78–1.11)
Enthesopathies2 (4)5 (92)0.68 (0.14–3.40)0.93 (0.17–5.07)
Arthralgias1 (2)1 (1)1.70 (0.11–26.84)1.09 (0.04–26.57)
ReA, enthesopathies, or arthralgias8 (14)16 (17)0.84 (0.39–1.86)0.57 (0.25–1.30)
  • * Adjusted by age, sex, and history of rheumatic disease or arthrosis, weight loss, and duration of diarrhea.